Related Experiment Video
Updated: Aug 25, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
[Bacterial granulomatous hepatitis]
Giuseppe Pasquale1, Ferdinando Scarano, Caterina Sagnelli
1Dipartimento di Medicina Pubblica, Clinica e Preventiva, Seconda Universita degli Studi di Napoli, Italy.
Abstract:
The liver may react to different infectious and non- infectious agents, developing granulomatous lesions which characterize granulomatous hepatitis. Granulomas of the liver are circumscribed inflammatory lesions (size from 50 to 300 mm) composed of epithelioid cells, varied numbers of mononuclear cells and eosinophils and multinucleated giant cells. They represent a specialized cell-mediated immune response to a wide variety of etiological factors. A broad spectrum of microorganisms may trigger hepatic granulomas. M. tuberculosis is the more frequent agent (~ 44%). Granulomatous hepatitis is characterized by a febrile illness with systemic signs and symptoms such as fatigue, sweating, shivering, hepatomegaly and/or splenomegaly, abnormalities in serum liver tests (aminotransferase, alkaline phosphatase). Liver biopsy provides diagnostic information in approximately 15-30% of cases, identifying directly the microbial agent with special microbial stains and polymerase chain reaction or finding distinctive microscopic features, suggestive of specific microorganisms. In such cases appropriate therapy is possible. Unfortunately in one third of cases is impossible to reach aetiological diagnosis on histological criteria alone. In these cases a therapeutic attempt with steroids, effective in the idiopathic granulomatous hepatitis, may be useful.
Insights
Granulomatous hepatitis involves liver inflammation from various causes, often triggered by infections like tuberculosis. Diagnosis can be challenging, but liver biopsy and steroid therapy may aid in management.
Area of Science:
- Hepatology
- Immunology
- Infectious Diseases
Context:
- Granulomatous hepatitis is an inflammatory liver condition.
- Characterized by granulomas, specialized immune responses to various etiological factors.
- Microorganisms, particularly Mycobacterium tuberculosis, are frequent triggers.
Purpose:
- To summarize the understanding of granulomatous hepatitis.
- To highlight diagnostic challenges and therapeutic approaches.
- To emphasize the role of liver biopsy and potential treatments.
Summary:
- Granulomatous hepatitis presents with symptoms like fever, fatigue, and enlarged liver/spleen, alongside abnormal liver tests.
- Liver biopsy aids diagnosis in 15-30% of cases by identifying microbial agents or characteristic features.
- Mycobacterium tuberculosis is the most common cause, implicated in approximately 44% of cases.
Impact:
- Facilitates diagnosis and targeted therapy for granulomatous hepatitis.
- Informs therapeutic strategies, including the use of steroids for idiopathic cases.
- Improves patient outcomes by guiding appropriate treatment based on etiological diagnosis.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Tuberculosis
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Gastritis II: Pathophysiology
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: